Fast technology meets slow money

Traditional capabilities built for financial services are quickly being outpaced by new technology capabilities, with everything from the shift to cloud to API-enabled capabilities to new payment schemes and microservices. The inefficiencies and costly capabilities for both SMB, enterprise, and consumers of the past will be rapidly replaced by the functionality of the future.

Our approach

Our approach is rooted in a deep understanding of the healthcare industry and a commitment to making a positive impact. We are currently focused on investing in companies that:

Significantly enhance patient outcomes

We support companies that are dedicated to advancing research and development in healthcare, paving the way for development of new healthcare products, treatments, therapies and cures.

Involve a substantial ‘Make-in-India’ component

We seek out companies which are focused on manufacturing top-notch healthcare products for domestic as well as global markets.

Harness technology to augment healthcare delivery

We intend to invest in companies that utilize advanced technologies like artificial intelligence, machine learning and data analytics to improve efficiency of healthcare delivery and outcome. In particular, we are keen on digital health concepts which focus on developing therapeutic ideas, analyzing medical data, and identifying patterns.